{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:09:32Z","timestamp":1761988172523},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2008,5,6]],"date-time":"2008-05-06T00:00:00Z","timestamp":1210032000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1007\/s11606-008-0622-0","type":"journal-article","created":{"date-parts":[[2008,5,5]],"date-time":"2008-05-05T17:46:16Z","timestamp":1210009576000},"page":"1177-1181","source":"Crossref","is-referenced-by-count":16,"title":["Does a History of Non-Vertebral Fracture Identify Women Without Osteoporosis for Treatment?"],"prefix":"10.1007","volume":"23","author":[{"given":"Kathryn M.","family":"Ryder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven R.","family":"Cummings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Palermo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne","family":"Satterfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas C.","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrianne C.","family":"Feldstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John T.","family":"Schousboe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann V.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristine","family":"Ensrud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for the Fracture Intervention Trial Research Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,5,6]]},"reference":[{"key":"622_CR1","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1359\/jbmr.1997.12.11.1761","volume":"12","author":"AC Looker","year":"1997","unstructured":"Looker AC, Orwoll ES, Johnston CC Jr, et al. Prevalence of low femoral bone density in older U.S. adults from NHANES III. J Bone Miner Res. 1997;12:1761\u20138.","journal-title":"J Bone Miner Res"},{"key":"622_CR2","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1210\/jc.2004-1568","volume":"90","author":"SA Wainwright","year":"2005","unstructured":"Wainwright SA, Marshall LM, Ensrud KE, et al. Hip fracture in women without osteoporosis. J Clin Endocrinol Metab. 2005;90:2787\u201393.","journal-title":"J Clin Endocrinol Metab"},{"key":"622_CR3","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1359\/jbmr.1998.13.8.1337","volume":"13","author":"KM Sanders","year":"1998","unstructured":"Sanders KM, Pasco JA, Ugoni AM, et al. The exclusion of high trauma fractures may underestimate the prevalence of bone fragility fractures in the community. J Bone Miner Res. 1998;13:1337\u201342.","journal-title":"J Bone Miner Res"},{"key":"622_CR4","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bone.2003.10.001","volume":"34","author":"SCE Schuit","year":"2004","unstructured":"Schuit SCE, van der Klift M, Weel AEAM, et al. Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study. Bone. 2004;34:195\u2013202.","journal-title":"Bone"},{"key":"622_CR5","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1359\/jbmr.2003.18.11.1947","volume":"18","author":"KL Stone","year":"2003","unstructured":"Stone KL, Seeley DG, Lui L-Y, et al. BMD at multiple sites and risk of fractures of multiple types: long-term results from the Study of Osteoporotic Fractures. J Bone Miner Res. 2003;18:1947\u201354.","journal-title":"J Bone Miner Res"},{"key":"622_CR6","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1001\/archinte.164.10.1108","volume":"164","author":"ES Siris","year":"2004","unstructured":"Siris ES, Chen YT, Abbott TA, et al. Bone mineral density thresholds for pharmacological intervention to prevent fractures. Arch Intern Med. 2004;164:1108\u201312.","journal-title":"Arch Intern Med"},{"key":"622_CR7","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1359\/jbmr.2000.15.4.721","volume":"15","author":"CM Klotzbuecher","year":"2000","unstructured":"Klotzbuecher CM, Ross PD, Landsman PB, Abbott TA III, Berger M. Patients with prior fracture have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res. 2000;15:721\u201339.","journal-title":"J Bone Miner Res"},{"key":"622_CR8","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1056\/NEJM199503233321202","volume":"332","author":"SR Cummings","year":"1995","unstructured":"Cummings SR, Nevitt MC, Browner WS, et al. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med. 1995;332:767\u201373.","journal-title":"N Engl J Med"},{"key":"622_CR9","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1136\/bmj.307.6912.1111","volume":"307","author":"T Nguyen","year":"1993","unstructured":"Nguyen T, Sambrook P, Kelly P, et al. Prediction of osteoporotic fractures by postural instability and bone density. BMJ. 1993;307:1111\u20135.","journal-title":"BMJ"},{"key":"622_CR10","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0140-6736(96)01440-7","volume":"348","author":"P Dargent-Molina","year":"1996","unstructured":"Dargent-Molina P, Faviier F, Grandjean H, et al. Fall-related factors and risk of hip fracture: the EPIDOS prospective study. Lancet. 1996;348:145\u20139.","journal-title":"Lancet"},{"key":"622_CR11","volume-title":"Physician\u2019s Guide to Prevention and Treatment of Osteoporosis","author":"National Osteoporosis Foundation","year":"1998","unstructured":"National Osteoporosis Foundation. Physician\u2019s Guide to Prevention and Treatment of Osteoporosis. Washington, DC: National Osteoporosis Foundation; 1998."},{"key":"622_CR12","doi-asserted-by":"crossref","first-page":"544","DOI":"10.4158\/EP.9.6.544","volume":"9","author":"American Association of Clinical Endocrinology","year":"2003","unstructured":"American Association of Clinical Endocrinology. Medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis: 2001 edition, with selected updates from 2003. Endocrine Pract. 2003;9:544\u201364.","journal-title":"Endocrine Pract"},{"key":"622_CR13","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s00198-006-0306-8","volume":"18","author":"ES Siris","year":"2007","unstructured":"Siris ES, Genant HK, Laster AJ, et al. Enhanced prediction of fracture risk combining vertebral fracture status and BMD. Osteoporos Int. 2007;18:761\u201370.","journal-title":"Osteoporos Int"},{"key":"622_CR14","first-page":"2614","volume":"157","author":"KE Ensrud","year":"1997","unstructured":"Ensrud KE, Black DM, Palermo L, et al. Treatment with alendronate prevents fractures in women at highest risk. Arch Intern Med. 1997;157:2614\u20137.","journal-title":"Arch Intern Med"},{"key":"622_CR15","doi-asserted-by":"crossref","first-page":"343","DOI":"10.4065\/80.3.343","volume":"80","author":"SA Quandt","year":"2005","unstructured":"Quandt SA, Thompson DE, Schneider DL, et al. Effect of alendronate on vertebral fracture risk in women with bone mineral density T scores of \u22121.6 to \u22122.5 at the femoral neck: the Fracture Intervention Trial. Mayo Clin Proc. 2005;80:343\u20139.","journal-title":"Mayo Clin Proc"},{"key":"622_CR16","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1001\/jama.280.24.2077","volume":"280","author":"SR Cummings","year":"1998","unstructured":"Cummings SR, Black DM, Thompson DE, et al. Effect of alendronate on risk of fracture in women with low bone mineral density but without vertebral fractures. JAMA. 1998;280:2077\u201382.","journal-title":"JAMA"},{"key":"622_CR17","doi-asserted-by":"crossref","first-page":"734","DOI":"10.7326\/0003-4819-142-9-200505030-00008","volume":"142","author":"JT Schousboe","year":"2005","unstructured":"Schousboe JT, Nyman JA, Kane RL, Ensrud KE. Cost-effectiveness of alendronate therapy for osteopenic postmenopausal women. Ann Intern Med. 2005;142:734\u201341.","journal-title":"Ann Intern Med"},{"key":"622_CR18","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1007\/s00198-005-1956-7","volume":"16","author":"JT Schousboe","year":"2005","unstructured":"Schousboe JT, Ensrud KE, Nyman JA, et al. Potential cost-effective use of spine radiographs to detect vertebral deformity and select osteopenic post-menopausal women for amino-bisphosphonate therapy. Osteoporosis Int. 2005;16:1883\u201393.","journal-title":"Osteoporosis Int"},{"key":"622_CR19","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1056\/NEJM200102013440503","volume":"344","author":"MR McClung","year":"2001","unstructured":"McClung MR, Geusens P, Miller PD, et al. Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. N Engl J Med. 2001;344:333\u201340.","journal-title":"N Engl J Med"},{"key":"622_CR20","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1359\/JBMR.050609","volume":"20","author":"E Sornay-Rendu","year":"2005","unstructured":"Sornay-Rendu E, Munoz F, Garnero P, et al. Identification of osteopenic women at high risk of fracture: the OFELY study. J Bone Miner Res. 2005;20:1813\u20139.","journal-title":"J Bone Miner Res"},{"key":"622_CR21","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00198-003-1514-0","volume":"15","author":"O Johnell","year":"2004","unstructured":"Johnell O, Kanis JA, Oden A, et al. Fracture risk following an osteoporotic fracture. Osteoporos Int. 2004;15:175\u20139.","journal-title":"Osteoporos Int"},{"key":"622_CR22","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1001\/archinte.164.10.1113","volume":"164","author":"PD Miller","year":"2004","unstructured":"Miller PD, Barlas S, Brenneman SK, et al. An approach to identifying osteopenic women at increased short-term risk of fracture. Arch Intern Med. 2004;164:1113\u201320.","journal-title":"Arch Intern Med"},{"issue":"suppl 3","key":"622_CR23","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1007\/BF01623005","volume":"3","author":"DM Black","year":"1993","unstructured":"Black DM, Reiss TF, Nevitt MC, et al. Design of the fracture intervention trial. Osteoporos Int. 1993;3(suppl):3S29\u2013S39.","journal-title":"Osteoporos Int"},{"key":"622_CR24","unstructured":"Genant HK, Jergas M, van Kuijk C, eds. Vertebral Fracture in Osteoporosis. San Francisco, Calif: Radiology Research and Educational Foundation; 1995:131\u2013147."},{"key":"622_CR25","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1001\/jama.282.14.1344","volume":"282","author":"ST Harris","year":"1999","unstructured":"Harris ST, Watts NB, Genant HK, et al. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis. JAMA. 1999;282:1344\u201352.","journal-title":"JAMA"},{"key":"622_CR26","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s001980050010","volume":"11","author":"J Reginster","year":"2000","unstructured":"Reginster J, Minne HW, Sorensen OH, et al. Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Osteoporos Int. 2000;11:83\u201391.","journal-title":"Osteoporos Int"},{"key":"622_CR27","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1359\/JBMR.040325","volume":"19","author":"CH Chestnut III","year":"2004","unstructured":"Chestnut CH III, Skag A, Christiansen C, et al. Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis. J Bone Miner Res. 2004;19:1241\u20139.","journal-title":"J Bone Miner Res"},{"key":"622_CR28","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","volume":"344","author":"RM Neer","year":"2001","unstructured":"Neer RM, Arnaud CD, Zanchetta JR, et al. Effect of parathyroid hormone (1\u201334) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med. 2001;344:1434\u201341.","journal-title":"N Engl J Med"},{"key":"622_CR29","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/jama.290.13.1729","volume":"290","author":"JA Cauley","year":"2003","unstructured":"Cauley JA, Robbins J, Chen Z, et al. Effects of estrogen plus progestin on risk of fracture and bone mineral density. the Women\u2019s Health Initiative Randomized Trial. JAMA. 2003;290:1729\u201338.","journal-title":"JAMA"},{"key":"622_CR30","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa062462","volume":"355","author":"E Barrett-Connor","year":"2006","unstructured":"Barrett-Connor E, Mosca L, Collins P, et al. Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women. N Engl J Med. 2006;355:125\u201337.","journal-title":"N Engl J Med"},{"key":"622_CR31","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1056\/NEJMoa074941","volume":"357","author":"KW Lyles","year":"2007","unstructured":"Lyles KW, Colon-Emeric CS, Magaziner JS, et al. Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med. 2007;357:1799\u20131809.","journal-title":"N Engl J Med"},{"key":"622_CR32","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00198-006-0211-1","volume":"18","author":"SJ Gallacher","year":"2007","unstructured":"Gallacher SJ, Gallagher AP, McQuillian C, et al. The prevalence of vertebral fracture amongst patients presenting with non-vertebral fractures. Osteoporos Int. 2007;18:185\u201392.","journal-title":"Osteoporos Int"},{"key":"622_CR33","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1359\/JBMR.051018","volume":"21","author":"DC Bauer","year":"2006","unstructured":"Bauer DC, Garnero P, Hochberg MC, et al. Pretreatment levels of bone turnover and the antifracture efficacy of alendronate: the Fracture Intervention Trial. J Bone Miner Res. 2006;21:292\u20139.","journal-title":"J Bone Miner Res"},{"key":"622_CR34","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00198-006-0218-7","volume":"18","author":"JT Schousboe","year":"2007","unstructured":"Schousboe JT, Bauer DC, Nyman KA, et al. Potential for bone turnover markers to cost-effectively identify and select post-menopausal osteopenic women at high risk of fracture for bisphosphonate therapy. Osteoporos Int. 2007;18:201\u201310.","journal-title":"Osteoporos Int"},{"key":"622_CR35","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/oxfordjournals.aje.a116315","volume":"135","author":"MC Nevitt","year":"1992","unstructured":"Nevitt MC, Cummings SR, Browner WS, et al. The accuracy of self-report of fractures in elderly women: evidence from a prospective study. Am J Epidemiol. 1992;135:490\u20139.","journal-title":"Am J Epidemiol"},{"key":"622_CR36","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1080\/14034940310017490","volume":"32","author":"YA Hundrup","year":"2004","unstructured":"Hundrup YA, Hoidrop S, Obel EB, Rasmussen NK. The validity of self-reported fractures among Danish female nurses: comparison with fractures registered in the Danish National Hospital Register. Scand J Pub Health. 2004;32:136\u201343.","journal-title":"Scand J Pub Health"},{"key":"622_CR37","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S0895-4356(01)00518-2","volume":"55","author":"RQ Ivers","year":"2002","unstructured":"Ivers RQ, Cummings RG, Mitchell P, Peduto AJ. The accuracy of self-reported fractures in older people. J Clin Epidemiol. 2002;55:452\u20137.","journal-title":"J Clin Epidemiol"}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-008-0622-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11606-008-0622-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-008-0622-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T17:32:34Z","timestamp":1559410354000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11606-008-0622-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5,6]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["622"],"URL":"https:\/\/doi.org\/10.1007\/s11606-008-0622-0","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"type":"print","value":"0884-8734"},{"type":"electronic","value":"1525-1497"}],"subject":[],"published":{"date-parts":[[2008,5,6]]}}}